基本信息
views: 4
Career Trajectory
Bio
Professor Lambert has an opioid career spanning >30y. As a non-clinician in a clinical environment his work is translational. His most recent clinical activity was with National consensus guidelines for perioperative use of opioids. As chair of BJA board and a member of RCoA council he has access to key decision makers in UK and wider via European equivalent societies. His opioid research is focussed on (i) opioid relevant ‘diseases’ e.g., pain and sepsis. (ii) Structure activity relationships to develop opioid ligands but is best known for work on NOP. Indeed, he has described a number of peptide and non-peptide agonists and antagonists that are now standard tools in NOP pharmacology including two new fluorescent peptides for MOP and NOP. These have been deployed in tissues with ultra low expression where radioligands are not useful. (iii) Describing the role of non-selective opioids in disease to reduce side effect profile; MOP-DOP and MOP-NOP.
Research Interests
Papers共 407 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
British Journal of Anaesthesiano. 3 (2024): 466-468
IUPHAR/BPS guide to pharmacology CITEno. 1 (2023)
PloS oneno. 5 (2023): e0284412-e0284412
British journal of pharmacologyno. 17 (2023): 2298-2314
BJA Open (2023): 100141-100141
Drug Action Haemodynamics and Immune Defencepp.67-70, (2023)
BJA open (2022): 100010-100010
Load More
Author Statistics
#Papers: 408
#Citation: 11558
H-Index: 52
G-Index: 88
Sociability: 8
Diversity: 3
Activity: 27
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn